Relugolix, sold under the brand names Orgovyx and Relumina among others, is a gonadotropin-releasing hormone antagonist (GnRH receptor antagonist) medication...
23 KB (1,944 words) - 16:28, 19 July 2024
Relugolix/estradiol/norethisterone acetate, sold under the brand names Myfembree and Ryeqo, is a fixed-dose combination hormonal medication which is used...
13 KB (894 words) - 04:48, 9 May 2024
are structurally related to GnRH – or small-molecules like elagolix and relugolix, which are structurally distinct from and unrelated to GnRH analogues...
6 KB (514 words) - 19:52, 27 March 2024
antagonistic effect, while other GnRH antagonists, such as elagolix and relugolix, are non-peptide and small-molecule compounds. GnRH antagonists compete...
19 KB (1,923 words) - 00:57, 21 March 2024
symptoms of metastases. In these people, GnRH antagonists like degarelix or relugolix are given instead, and can also rapidly reduce testosterone levels. Reducing...
76 KB (8,865 words) - 11:41, 22 July 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
9 KB (881 words) - 13:39, 28 July 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
109 KB (11,139 words) - 21:26, 2 August 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
34 KB (3,479 words) - 11:56, 23 July 2024
introduction of elagolix in the United States and Canada was followed by that of relugolix (brand name Relumina), the next second-generation GnRH antagonist, in...
64 KB (6,216 words) - 09:26, 11 May 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
49 KB (5,368 words) - 15:05, 11 June 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
24 KB (2,462 words) - 20:32, 3 July 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
11 KB (1,114 words) - 19:59, 4 April 2022
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
14 KB (981 words) - 11:38, 23 March 2024
Exemestane L02BX01 Abarelix L02BX02 Degarelix L02BX03 Abiraterone L02BX04 Relugolix L02BX53 Abiraterone and prednisolone "ATC (Anatomical Therapeutic Chemical...
2 KB (239 words) - 00:26, 31 December 2023
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
21 KB (2,261 words) - 03:48, 13 June 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
18 KB (1,667 words) - 19:52, 16 July 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
35 KB (3,024 words) - 21:35, 10 March 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
5 KB (237 words) - 21:04, 8 February 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
8 KB (794 words) - 07:50, 29 April 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
51 KB (3,928 words) - 03:25, 25 July 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
27 KB (3,150 words) - 08:47, 11 April 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
18 KB (2,100 words) - 08:59, 23 July 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
108 KB (11,654 words) - 08:32, 16 May 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
15 KB (1,179 words) - 23:11, 26 January 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
11 KB (855 words) - 04:14, 1 June 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
10 KB (799 words) - 21:26, 8 June 2024
orally active GnRH antagonist to be introduced for medical use 2019: Relugolix is the second orally active GnRH antagonist to be introduced for medical...
158 KB (15,043 words) - 06:11, 3 August 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
5 KB (254 words) - 18:23, 18 September 2023
non-peptide and orally active GnRH antagonists, elagolix (Orilissa) and relugolix (Relumina), were introduced for medical use in 2018 and 2019, respectively...
231 KB (25,190 words) - 01:33, 23 July 2024
Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone acetate)...
41 KB (3,390 words) - 02:48, 10 July 2024